DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Etges T, Karolia K, Grint T. et al.
An observational postmarketing safety registry of patients in the UK, Germany,
and Switzerland who have been prescribed Sativex(®) (THC:CBD, nabiximols)
oromucosal spray.
Ther Clin Risk Manag 2016;
12: 1667-1675
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.